Open AccessAlpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease
Author(s) -
Clara Antoury,
Rocío López,
Nizar N. Zein,
James K. Stoller,
Naim Alkhouri
Publication year - 2015
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v7.i10.1427
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , alcoholic liver disease , gastroenterology , steatohepatitis , liver biopsy , liver transplantation , liver disease , hepatic encephalopathy , hepatitis c , chronic liver disease , ascites , alcoholic hepatitis , biopsy , pathology , fatty liver , transplantation , disease
To evaluate the association between alpha-1 antitrypsin deficiency (A1ATD) and hepatocellular carcinoma (HCC) in patients with end-stage liver disease (ESLD).